New York [US], January 20 (ANI): A study published in journal Human Gene Therapy shows that gene editing therapies, including CRISPR-Cas frameworks, offer the possibility to address transformations causing inherited retinal degenerations, a leading cause of blindness.
New Delhi [India], January 7 (ANI/Digpu): Biotechnology plays a definitive role in meeting the unmet medical needs and the advancement of the healthcare sector by bringing innovative new technologies and therapies to market.
Washington [US], January 5 (ANI): Researchers at The University of Texas MD Anderson Cancer Center have discovered that a protein called NF-kappa B-inducing kinase (NIK) is essential for the shift in metabolic activity that occurs with T cell activation, making it a critical factor in regula
New Delhi [India], December 29 (ANI): Non-judicious use of therapies that have not been established for COVID-19 treatment are responsible for putting "immune pressure on virus" and leads to virus mutations, ICMR Director-General Dr Balram Bhargava said on Tuesday.
Washington [US], December 26 (ANI): According to Penn State College of Medicine researchers, the absence of a protein that works to prevent tumour formation may explain why some patients are resistant to common cancer therapy.
Washington [US], December 22 (ANI): The absence of a protein that works to prevent tumour formation may explain why some patients are resistant to common cancer therapy, according to Penn State College of Medicine researchers.
Washington [US], December 13 (ANI): Study published in the journal cell online revealed that by targeting a single protein cell which appears essential for SARS-CoV-2 to replicate could control the spread of the virus.
Washington [US], December 10 (ANI): A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.
Washington [US], December 4 (ANI): A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.
Washington [US], November 28 (ANI): Scientists at UC San Francisco and Princeton University present complementary strategies to crack this problem with "smart" cell therapies--living medicines that remain inert unless triggered by combinations of proteins that only ever appear together in ca
Washington [US], November 15 (ANI): To suppress the impact of lung fibrosis, concerning COVID patients, scientists have been developing new treatment therapies, targeting the complications developed by the mutual relationship between the two.
Washington [US], November 11 (ANI): A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.